PMS-TADALAFIL

Pharmascience Inc🇨🇦 Health Canada

Approval Id: 0a04f2732102380f
Drug Approval Canada Name: PMS-TADALAFIL
Product Name: PMS-TADALAFIL
Status: Marketed
Status Date: 2020-05-21
Original Market Date: 2016-07-12
Din: 02409445
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:12.12
Atc Original: G04BE08 TADALAFIL
Atc Name: g 04 be 08
Aig Number: 0149485002
Company Name: Pharmascience Inc
Company Address: 100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path: /organization/pharmascience-inc

TADALAFIL

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

0a04f2732102380f

Type

Standard